- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05987735
Psycho-education Program BLAME-LESS and It's Effect on Traumarelated Shame and Guilt (BLAME-LESS)
January 8, 2025 updated by: Karakter Kinder- en Jeugdpsychiatrie
BLAME-LESS STUDY: a Two-arm Randomized Controlled Trial Evaluating the Effects of an Online Psycho-education Program for Adolescents Who Experienced (sexual) Violence.
The primary objective of the BLAME-LESS study is to examine the effectiveness of an online psychoeducation program in reducing trauma-related feelings of shame and guilt in adolescents who experienced sexual or physical abuse .
Study Overview
Detailed Description
The study follows a two-arm RCT (n=34).
The effects of a brief online psychoeducation program will be compared, with a waiting-list control group.
The intervention aims to reduce feelings of trauma-related shame and guilt that adolescents experience regarding their own defense responses during and after (sexual) violence.
Assessments take place after screening, at baseline, two weeks after allocation to the intervention or waiting-list, and, only for the waiting-list participants, seven weeks after allocation to the intervention.
Study Type
Interventional
Enrollment (Estimated)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Overijssel
-
Almelo, Overijssel, Netherlands, 7600 AP
- Karakter kinder- en jeugdpsychiatrie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- the participant experienced one or more traumatic life events, including (sexual) violence as indicated by the CTSQ;
- the participant reported one or more feelings of guilt and/or shame on the CERQ (items 1 and/or 10 and/or 19 and/or 28)
- the participant being fluent in written and spoken Dutch;
- the participant is motivated and available for a period of seven weeks to engage in the study, including the psychoeducation program BLAME-LESS, and commit to the assessments.
Exclusion Criteria:
- acute suicidal behavior or suicidal ideations requiring immediate hospitalization;
- the participant has already read the book that this program is based upon: "Paralyzed with Fear" (In Dutch: Verlamd van Angst, van Minnen 2017), or has been intensively informed otherwise in the past 12 months by a psychologist about common defense responses during and after trauma;
- Cognitive Impairments (IQ < 70);
- the participant has a brother or sister in the present study;
- the participant is already involved in trauma-focused treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BLAME-LESS Program
If allocated to the intervention group, participants will have direct access to the online intervention for two weeks after allocation.
|
The BLAME-LESS program was designed to educate about common defense responses that may occur during and after (sexual) violence.
The main goal of the program is to reduce the feelings of shame and/or guilt related to these responses.
The program was created in collaboration with licensed developmental and clinical psychologists with extensive psycho-trauma expertise, young adults who are experienced experts, visual artists, and web designers.
The program is offered via a website and consists of three modules.
|
|
No Intervention: Waiting-list control group
When a participant is assigned to the waiting-list control group, he or she has a two-week waiting period, after which the participant will have access to the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary outcome: Changes in Feelings of Shame and Guilt
Time Frame: The SGATS will be assessed at before treatment (T1 = Week 1), after treatment (T2 = Week 4, T3 = week 7)
|
The primary objective of the BLAME-LESS study is to examine the effectiveness of an online psychoeducation program, BLAME-LESS, compared to a waiting-list control group of adolescents (12 - 18 years) who experienced sexual or physical abuse in reducing trauma-related feelings of shame and guilt.
The Shame and Guilt After Trauma Scale (SGATS) (Aakvaag et al., 2016) measures trauma-related shame and guilt.
The SGATS consists of nine items, four on trauma-related feelings of shame and five on trauma-related feelings of guilt (Aakvaag et al., 2016).
Each question can be answered on a 3-point Likert scale (0 = no, 1 = yes, a little, 2 = yes, a lot).
|
The SGATS will be assessed at before treatment (T1 = Week 1), after treatment (T2 = Week 4, T3 = week 7)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary outcome: Changes in Posttraumatic Stress Symptoms
Time Frame: The KJTS will be assessed before treatment (T1 = Week 1) and after treatment (T2 = Week 4, T3 = Week 7).
|
The second objective of the research is to examine the effects of the intervention on PTSD symptoms.
The Dutch version of the Child and Adolescent Trauma Screener (KJTS-NL; Kooij & Lindauer, 2019) is a questionnaire for children and adolescents that serves as a screening tool for PTSD symptoms (Sachser et al., 2017).
The severity of PTSD symptoms is measured with 20 items, rated on a 4-point Likert scale (range 1-4).
A total score below 15 suggests no (clinical) indication of the presence of a PTSD classification, a score between 15 and 20 suggests the possible presence of a clinical PTSD classification, and a score above 20 suggests an increased chance of the presence of a PTSD classification.
|
The KJTS will be assessed before treatment (T1 = Week 1) and after treatment (T2 = Week 4, T3 = Week 7).
|
|
Secondary outcome: Changes in Depression and Anxiety Symptoms
Time Frame: The PROMIS will be assessed before treatment (T1 = Week 1) and after treatment (T2 = Week 4, T3 = Week 7)
|
The third objective of the research is to examine the effects of the intervention on anxiety and depression symptoms.
The Patient-Reported Outcomes Measurement Information System (PROMIS; Terwee et al., 2014) measures Anxiety and Depression symptoms.
The lists consist of a dynamic set of item banks based on Computerized Adaptive Testing (CAT).
Both questionnaires consist of 8 items.
Each question can be answered as follows: never, almost never, sometimes, often, very often.
|
The PROMIS will be assessed before treatment (T1 = Week 1) and after treatment (T2 = Week 4, T3 = Week 7)
|
|
Secondary outcome: Changes in Posttraumatic Cognition
Time Frame: The CPTCI will be assessed before treatment (T1 = Week 1) and after treatment (T2 = Week 4, T3 = Week 7)
|
The fourth objective of the research is to examing the effects of the intervention on posttraumatic cognitions.
The Child Posttraumatic Cognitions Inventory (CPTCI; Meiser-Stedman et al., 2009) is a self-report questionnaire that measures trauma-related cognitions in children and adolescents.
The questionnaire consists of two subscales (permanent and disturbing change subscale, CPTCI-PC; fragile person in a scary world subscale, CPTCI-SW) with a total of 25 items that can be answered on a four-point Likert scale (ranging from 1 (strongly disagree) to 4 (strongly agree).
The English version of the CPTCI has been validated in children aged-6-18 years.
The Dutch CPTCI has good reliability and validity (Diehle et al., 2015), high internal consistency (Cronbach's alpha 0.86-0.93),
and good convergent validity.
|
The CPTCI will be assessed before treatment (T1 = Week 1) and after treatment (T2 = Week 4, T3 = Week 7)
|
|
Secondary outcome: Changes in motivation and disclosure
Time Frame: The TPEQ will be assessed before treatment (T1 = Week 1) and after treatment (T2 = Week 4, T3 = Week 7)
|
The fifth objective of the research is to examing the effects of the intervention on motivation to engage in traumafocused treatment and to disclose traumatic memories.
The Treatment Program and Evaluation Questionnaire (TPEQ; Murphy et al., 2009) assesses readiness and motivation for trauma-focused treatments (Murphy et al., 2009).
The questions were answered on a 7-point Likert scale (ranging from 1 = strongly disagree to 7 = strongly agree).
A higher score indicates greater willingness and motivation for treatment.
|
The TPEQ will be assessed before treatment (T1 = Week 1) and after treatment (T2 = Week 4, T3 = Week 7)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nanda Lambregts-Rommelse, Prof.dr, Karakter kinder- en jeugdpsychiatrie
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2023
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
July 5, 2023
First Submitted That Met QC Criteria
August 4, 2023
First Posted (Actual)
August 14, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 8, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Ontschuldig
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trauma
-
Humacyte, Inc.CompletedTrauma | Trauma Injury | Trauma, Multiple | Trauma BluntUkraine
-
Wonju Severance Christian HospitalNational Research Foundation of KoreaCompletedTrauma Injury | Trauma, MultipleKorea, Republic of
-
Arrowhead Regional Medical CenterCompletedTrauma Injury | Trauma Blunt | Vascular TraumaUnited States
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedTrauma Injury | Trauma, MultipleTurkey
-
University Hospital, AngersRecruiting
-
Rabin Medical CenterIsraeli Ministry of SecurityUnknown
-
Hospital Departamental de VillavicencioCooperative University of Colombia; Clínica PrimaveraRecruitingTrauma Injury | Trauma Patients in ICU | Trauma (Including Fractures) | Trauma Patients | Trauma ICU PatientsColombia
-
Oslo University HospitalUniversity of Oslo; Sunnaas Rehabilitation Hospital; South-Eastern Norway Regional...RecruitingTrauma Injury | Trauma, Multiple | PolytraumaNorway
-
Chang, Steve S., M.D.Santa Barbara Cottage Hospital; Accumetrics, Inc.CompletedHead Injury Trauma BluntUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Francophone Pediatric Resuscitation...Completed
Clinical Trials on BLAME-LESS
-
University of Texas Southwestern Medical CenterCompletedAnorexia Nervosa | Binge-Eating Disorder | Bulimia Nervosa | Eating DisordersUnited States
-
Karolinska InstitutetNot yet recruitingObesity &Amp; OverweightSweden
-
Vanderbilt UniversityTerminatedPhysical Activity | Type 2 Diabetes | Sedentary Behavior | Sedentary TimeUnited States
-
West China Second University HospitalActive, not recruitingUterine Sarcoma | Uterine Fibroid | Uterine LeiomyosarcomaChina
-
University of California, San DiegoCompletedBreast Cancer | Sedentary Behavior | Sedentary TimeUnited States
-
Dialisis MadariagaUnknown
-
West China Second University HospitalNot yet recruitingAdenomyosis | Enlarged Uterus | Uterine Fibroids (UF)China
-
Vanderbilt UniversityCompletedHeart Diseases | Cardiovascular Diseases | Physical Activity | Sedentary BehaviorUnited States
-
Vanderbilt UniversityCompletedPhysical Activity | Type 2 Diabetes | Sedentary BehaviorUnited States